HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2023 May 16

PMID 37189349

Authors

Kejia Zhao

Guanyu Zhou

Yu Liu

Jian Zhang

Yaohui Chen

Lunxu Liu

Gao Zhang

Affiliations

Soon will be listed here.

Abstract

The 70 kDa heat shock proteins (HSP70s) are a group of highly conserved and inducible heat shock proteins. One of the main functions of HSP70s is to act as molecular chaperones that are involved in a large variety of cellular protein folding and remodeling processes. HSP70s are found to be over-expressed and may serve as prognostic markers in many types of cancers. HSP70s are also involved in most of the molecular processes of cancer hallmarks as well as the growth and survival of cancer cells. In fact, many effects of HSP70s on cancer cells are not only related to their chaperone activities but rather to their roles in regulating cancer cell signaling. Therefore, a number of drugs directly or indirectly targeting HSP70s, and their co-chaperones have been developed aiming to treat cancer. In this review, we summarized HSP70-related cancer signaling pathways and corresponding key proteins regulated by the family of HSP70s. In addition, we also summarized various treatment approaches and progress of anti-tumor therapy based on targeting HSP70 family proteins.

Citing Articles

ENO1/Hsp70 Interaction Domains: In Silico and In Vitro Insight for a Putative Therapeutic Target in Cancer.

Gulotta M, Perricone U, Rubino P, Bonura A, Feo S, Giallongo A ACS Omega. 2025; 10(5):5036-5046.

PMID: 39959117 PMC: 11822713. DOI: 10.1021/acsomega.4c10808.

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E Antioxidants (Basel). 2025; 14(1).

PMID: 39857442 PMC: 11760872. DOI: 10.3390/antiox14010108.

Bioinformatics analysis and alternative polyadenylation in Heat Shock Proteins 70 (HSP70) family members.

Shriya S, Paul R, Singh N, Afza F, Jain B Int J Physiol Pathophysiol Pharmacol. 2025; 16(6):138-151.

PMID: 39850245 PMC: 11751548. DOI: 10.62347/CWPE7813.

Grapefruit-Derived Vesicles Loaded with Recombinant HSP70 Activate Antitumor Immunity in Colon Cancer In Vitro and In Vivo.

Garaeva L, Komarova E, Emelianova S, Putevich E, Konevega A, Margulis B Biomedicines. 2025; 12(12.

PMID: 39767665 PMC: 11674020. DOI: 10.3390/biomedicines12122759.

Molecular chaperones: Guardians of tumor suppressor stability and function.

Heritz J, Backe S, Mollapour M Oncotarget. 2024; 15:679-696.

PMID: 39352796 PMC: 11444336. DOI: 10.18632/oncotarget.28653.

References

Wang N, Wang Z, Peng C, You J, Shen J, Han S . Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Carcinogenesis. 2014; 35(11):2544-54. DOI: 10.1093/carcin/bgu187. View

Liu J, Liu J, Guo S, Liu H, Li S . HSP70 inhibitor combined with cisplatin suppresses the cervical cancer proliferation in vitro and transplanted tumor growth: An experimental study. Asian Pac J Trop Med. 2017; 10(2):184-188. DOI: 10.1016/j.apjtm.2017.01.020. View

Chugh R, Sangwan V, Patil S, Dudeja V, Dawra R, Banerjee S . A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Sci Transl Med. 2012; 4(156):156ra139. PMC: 3656604. DOI: 10.1126/scitranslmed.3004334. View

Liu P, Cheng H, Roberts T, Zhao J . Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009; 8(8):627-44. PMC: 3142564. DOI: 10.1038/nrd2926. View

Ding L, Zhang J, Yang S, Wu J, Su T, Wang W . Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma. Front Endocrinol (Lausanne). 2022; 13:890218. PMC: 9362981. DOI: 10.3389/fendo.2022.890218. View

Massey A, Williamson D, Browne H, Murray J, Dokurno P, Shaw T . A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol. 2009; 66(3):535-45. DOI: 10.1007/s00280-009-1194-3. View

Liu J, Bao J, Hao J, Peng Y, Hong F . HSP70 inhibits high glucose-induced Smad3 activation and attenuates epithelial-to-mesenchymal transition of peritoneal mesothelial cells. Mol Med Rep. 2014; 10(2):1089-95. DOI: 10.3892/mmr.2014.2279. View

Adam C, Baeurle A, Brodsky J, Wipf P, Schrama D, Becker J . The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma. PLoS One. 2014; 9(4):e92041. PMC: 3973671. DOI: 10.1371/journal.pone.0092041. View

Walerych D, Olszewski M, Gutkowska M, Helwak A, Zylicz M, Zylicz A . Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions. Oncogene. 2009; 28(48):4284-94. DOI: 10.1038/onc.2009.281. View

10.

Ko S, Kim J, Na D, Park S, Park S, Hyun J . A small molecule inhibitor of ATPase activity of HSP70 induces apoptosis and has antitumor activities. Chem Biol. 2015; 22(3):391-403. DOI: 10.1016/j.chembiol.2015.02.004. View

11.

Kelber J, Panopoulos A, Shani G, Booker E, Belmonte J, Vale W . Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009; 28(24):2324-36. PMC: 2749668. DOI: 10.1038/onc.2009.97. View

12.

Jaattela M, Saksela K, Saksela E . Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors alpha and beta. Eur J Immunol. 1989; 19(8):1413-7. DOI: 10.1002/eji.1830190810. View

13.

Zhou Y, Ma J, Zhang J, He L, Gong J, Long C . Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70. Oncol Rep. 2016; 37(1):313-322. DOI: 10.3892/or.2016.5286. View

14.

Mayer M, Schroder H, Rudiger S, Paal K, Laufen T, Bukau B . Multistep mechanism of substrate binding determines chaperone activity of Hsp70. Nat Struct Biol. 2000; 7(7):586-93. DOI: 10.1038/76819. View

15.

Lan Y, Li Y, Chen M, Tang L, Ren H . [Immunotherapy with a chimeric AFP and HSP70 gene DNA vaccine targeting on a murine hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi. 2006; 14(7):510-3. View

16.

Krause S, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G . Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial. Clin Cancer Res. 2004; 10(11):3699-707. DOI: 10.1158/1078-0432.CCR-03-0683. View

17.

Bailey C, Budina-Kolomets A, Murphy M, Nefedova Y . Efficacy of the HSP70 inhibitor PET-16 in multiple myeloma. Cancer Biol Ther. 2015; 16(9):1422-6. PMC: 4622955. DOI: 10.1080/15384047.2015.1071743. View

18.

Zong J, Peng Q, Wang Q, Zhang T, Fan D, Xu X . Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects. Oncol Rep. 2009; 22(4):953-61. DOI: 10.3892/or_00000522. View

19.

Calderwood S, Khaleque M, Sawyer D, Ciocca D . Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006; 31(3):164-72. DOI: 10.1016/j.tibs.2006.01.006. View

20.

Wang Z, Xing Y, Liu B, Lu L, Huang X, Ge C . Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models. Chin J Cancer. 2012; 31(6):295-305. PMC: 3777491. DOI: 10.5732/cjc.011.10384. View